Massachusetts General Hospital
David Christopher Christian
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Lung Cancer
Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 15000 participants |
| Official Title : | Molecular and Genetic Analysis of Lung Cancer |
| Actual Study Start Date : | 1993-06 |
| Estimated Primary Completion Date : | 2026-09 |
| Estimated Study Completion Date : | 2026-09 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114